Skip to content

Advertisement

  • Poster presentation
  • Open Access

Substituted flavones: a promising scaffold in the fight against malaria

  • 1, 2,
  • 3,
  • 3,
  • 4,
  • 1,
  • 2 and
  • 1
Malaria Journal201413 (Suppl 1) :P64

https://doi.org/10.1186/1475-2875-13-S1-P64

  • Published:

Keywords

  • Malaria
  • Flavone
  • Antimalarial Activity
  • Selectivity Index
  • Antiplasmodial Activity

Background

Ever since 2008, when evidence of artemisinin resistant malaria was highlighted in Western Cambodia [1], the need for new drugs with an original structure and novel mechanisms of action is even more pressing. The study of traditional remedies such as Cinchona bark or Artemisia aerial parts led to the discovery of the most potent antimalarials, bearing out that nature is still an incredible source of inspiration. Based on this approach, we are developing new synthetic antimalarial agents with an original structure inspired by nature.

Material and methods

In vitro antiplasmodial activity is evaluated against two strains of P. falciparum (multiresistant K1 and chloroquino-resistant 7G8) with two different methods: the inhibition of 3[H]-hypoxanthine incorporation assay and the Plasmodium-LDH immunoassay detection kit. Cytotoxicity assays are performed on two murine cell types (L6 and Hepa) in order to estimate the selectivity index, with two different viability tests: the resazurine assay and an MTT-based approach. In vivo activity is performed according to Peters’ experiment [2] on P. berghei ANKA murine model at a dosing regimen of 100 mg/kg intraperitoneally.

Results

The isolation of an in vitro active biflavonoid from Campno-sperma panamense (Anacardiaceae, IC50 = 480 nM, P. falciparum K1), led us to the development of simplified synthetic analogs (MR series) with improved pharmacological and pharmacokinetic profiles. Notably one of them (MR70) exhibits a partial in vivo antimalarial activity with a reduction of parasitaemia by 45% on day 4.

Conclusion

We described here the first substituted flavone showing an in vivo antimalarial activity in a murine model. This scaffold should be promising in the fight against malaria. To understand its mechanism of action, we are currently running differential metabolomics analysis by solid NMR (coll. Pr. J. I. Namer, Strasbourg, France) to highlight some potential impact on Plasmodium metabolic pathways.

Authors’ Affiliations

(1)
Laboratoire d’Innovation Thérapeutique, Faculté de Pharmacie, UMR CNRS-Unistra 7200, Illkirch, France
(2)
Faculté de Médecine, Institut de Parasitologie et de Pathologie Tropicale de Strasbourg, Strasbourg, France
(3)
Centre d’Etudes et de Recherches sur le Médicament en Normandie, Université de Caen Basse-Normandie, Caen, France
(4)
Swiss Tropical and Public Health Institute, Basel, Switzerland

References

  1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM: Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008, 359: 2619-3620. 10.1056/NEJMc0805011.View ArticlePubMedGoogle Scholar
  2. Peters W, Robinson BL: Handbook of animal models of infection: experimental models in antimicrobial chemotherapy. Malaria. Edited by: Academic Press. 1999, 757-773.Google Scholar
  3. Weniger B, Vonthron-Sénécheau C, Arango GJ, Kaiser M, Brun R, Anton R: A bioactive biflavonoid from Campnosperma panamense. Fitoterapia. 2004, 75: 764-767. 10.1016/j.fitote.2004.09.015.View ArticlePubMedGoogle Scholar

Copyright

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement